Mark Olfson, MD, MPH

Generalizability in Clinical Trials of Substance Abuse

January 25, 2017

If clinical trials by design exclude as many as 85% of individuals with a target disorder, how can these studies be representative of the clinical population? Discover in this...

Carlos Blanco , Aimee N. Campbell , Melanie M. Wall , et al

Original Research

Generalizability of Neuroimaging Studies in 5 Common Psychiatric Disorders Based on the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)

December 28, 2016

Carlos Blanco , Melanie M. Wall , Martin A. Lindquist , et al

Supplement Article

Injectable Antipsychotics in Schizophrenia

September 30, 2016

Read the recommendations of experts on the use of long-acting injectable antipsychotic medications in patients with schizophrenia.

Christoph U. Correll , Leslie Citrome , Peter M. Haddad , et al

Article

Antipsychotic Treatment of Adults in the United States

October 21, 2015

Mark Olfson , Marissa King , Michael Schoenbaum

InfoPack

Clinical and Cost Implications of Treating Schizophrenia: Safety, Efficacy, Relapse Prevention, and Patient Outcomes

August 26, 2014

John M. Kane , Christoph U. Correll , Philip D. Harvey , et al

Original Research

National Trends in Second-Generation Antipsychotic Augmentation for Nonpsychotic Depression

May 15, 2014

Tobias Gerhard , Ayse Akincigil , Christoph U. Correll , et al

Original Research

Trends in Office-Based Mental Health Care Provided by Psychiatrists and Primary Care Physicians

March 15, 2014

Mark Olfson , Kurt Kroenke , Shuai Wang , et al

Original Research

National Trends in Long-Term Use of Antidepressant Medications: Results From the US National Health and Nutrition Examination Survey

December 10, 2013

Ramin Mojtabai , Mark Olfson

Article

Probability and Predictors of First Treatment Contact for Anxiety Disorders in the United States: Analysis of Data From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)

November 15, 2013

Miren Iza , Mark Olfson , Donna Vermes , et al

Original Research

National Trends in the Office-Based Prescription of Schedule II Opioids

September 15, 2013

Mark Olfson , Shuai Wang , Miren Iza , et al

Original Research

Quality of Life Following Remission of Mental Disorders: Findings From the National Epidemiologic Survey on Alcohol and Related Conditions

May 15, 2013

Jose M. Rubio , Mark Olfson , Laura Villegas , et al

Original Research

Trends in Office-Based Treatment of Adults With Stimulants in the United States

January 15, 2013

Mark Olfson , Carlos Blanco , Shuai Wang , et al

Generalizability in Clinical Trials of Substance Abuse

Generalizability of Neuroimaging Studies in 5 Common Psychiatric Disorders Based on the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)

Injectable Antipsychotics in Schizophrenia

Antipsychotic Treatment of Adults in the United States

Clinical and Cost Implications of Treating Schizophrenia: Safety, Efficacy, Relapse Prevention, and Patient Outcomes

National Trends in Second-Generation Antipsychotic Augmentation for Nonpsychotic Depression

Trends in Office-Based Mental Health Care Provided by Psychiatrists and Primary Care Physicians

National Trends in Long-Term Use of Antidepressant Medications: Results From the US National Health and Nutrition Examination Survey

Probability and Predictors of First Treatment Contact for Anxiety Disorders in the United States: Analysis of Data From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)

National Trends in the Office-Based Prescription of Schedule II Opioids

Quality of Life Following Remission of Mental Disorders: Findings From the National Epidemiologic Survey on Alcohol and Related Conditions

Trends in Office-Based Treatment of Adults With Stimulants in the United States

ELSEWHERE:

FOLLOW US:

Mark Olfson, MD, MPH

Generalizability in Clinical Trials of Substance Abuse

Generalizability of Neuroimaging Studies in 5 Common Psychiatric Disorders Based on the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)

Injectable Antipsychotics in Schizophrenia

Antipsychotic Treatment of Adults in the United States

Clinical and Cost Implications of Treating Schizophrenia: Safety, Efficacy, Relapse Prevention, and Patient Outcomes

National Trends in Second-Generation Antipsychotic Augmentation for Nonpsychotic Depression

Trends in Office-Based Mental Health Care Provided by Psychiatrists and Primary Care Physicians

National Trends in Long-Term Use of Antidepressant Medications: Results From the US National Health and Nutrition Examination Survey

Probability and Predictors of First Treatment Contact for Anxiety Disorders in the United States: Analysis of Data From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)

National Trends in the Office-Based Prescription of Schedule II Opioids

Quality of Life Following Remission of Mental Disorders: Findings From the National Epidemiologic Survey on Alcohol and Related Conditions

Trends in Office-Based Treatment of Adults With Stimulants in the United States

Watch the New PsychCase360

Subscribe to readmore articles

Subscribe to read
more articles